India Today on MSN15h
India approves living drug to treat blood cancer: All about Qartemi and how it works
The second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...
Daily2d
Sanofi Healthcare India gets CDSCO Panel nod to study Nirsevimab
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
The Hindu21d
CDSCO approves Wockhardt’s drug Miqnaf to treat CABP in adults
Drugmaker Wockhardt on Thursday announced Central Drugs Standard Control Organization (CDSCO) approval for use of ... plans to launch Miqnaf in the Indian market in coming few months, Wockhardt ...
Indiatimes27d
Over 40 batches of drugs are 'not of standard': CDSCO survey
The CDSCO, which is the apex body responsible for approval of new drugs and clinical trials, has issued an alert regarding this. According to latest data, they found 41 batches of drugs ...
ThePrint on MSN4d
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in India
Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
Business Insider1mon
MannKind, Cipla: CDSCO in India approves Afrezza Inhalation Powder in India
MannKind (MNKD) and Cipla announced that the Central Drugs Standard Control Organisation in India has approved Afrezza Inhalation Powder in adults. The CDSCO decision follows existing approvals in ...
The Hindu28d
Local clinical trial waiver for selected drugs is a double-edged sword says experts
“India’s decision to waive local clinical trials for drugs ... of CDSCO as early as 2023. Also voices from the industry, state that the move will expedite the approval process for new drugs ...
devdiscourse6d
India Bans Import of Refurbished Medical Devices to Boost Local Industry
The Central Drugs Standard Control Organisation (CDSCO) has banned the import of refurbished medical devices, reinforcing India’s commitment to patient safety and strengthening the local industry's ...
Daily12d
CDSCO Panel approves Dr Reddys proposal to increase patients from 241 to 265 in India for anticancer drug Nivolumab study
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
Businessworld21d
Wockhardt Stock Gains 5% On Drug Approval
The share price of Wockhardt rose by 5 per cent in the Friday trading session following the approval ... by the Indian drug regulator. The Central Drugs Standard Control Organisation (CDSCO ...
Pharmabiz22d
CDSCO brings clinical trial site addition and change of PI applications to online mode
The Central Drugs Standard Control Organisation ... online system of Sugam Portal under Post Approval Changes, as it is stopping the offline submission process from December 1, 2023. In the beginning ...
The New Indian Express28d
India's drug regulator finds 41 drug samples not of standard quality
NEW DELHI: India ... drug samples were identified as spurious drugs. Out of two samples, one drug sample was picked by the Bihar Drugs Control Authority and another sample was picked by CDSCO ...